Large-scale testing (Phase 3)Study completedNCT01755364
What this trial is testing
A Trial to Assess the Immunogenicity and Safety of the Trivalent Virosomal Influenza Vaccine, Formulation of 2012-2013, in Healthy Subjects Aged Over 3 Years Old to 18 Years Old
Who this might be right for
Influenza
Adimmune Corporation 122